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Abstract
Purpose: To compare the levels of gene expression for enzymes involved in production and elimination 
of reactive oxygen/nitrogen species (ROS/RNS) in normal human corneal cells (NL cells) with those in 
human corneal cells with keratoconus (KC cells) in vitro.
Methods: Primary NL and KC stromal fibroblast cultures were incubated with apocynin 
(an inhibitor of NADPH oxidase) or N‑nitro‑L‑arginine (N‑LLA; an inhibitor of nitric oxide synthase). ROS/RNS 
levels were measured using an H2DCFDA fluorescent assay. The RT2 Profiler™ PCR Array for Oxidative Stress 
and Antioxidant Defense was used for initial screening of the NL and KC cultures. Transcription levels for genes 
related to production or elimination of ROS/RNS were analyzed using quantitative PCR. Immunohistochemistry 
was performed on 10 intact human corneas using antibodies against SCARA3 and CPSF3.
Results: Array screening of 84 antioxidant-related genes identified 12 genes that were differentially 
expressed between NL and KC cultures. Compared with NL cells, quantitative PCR showed that KC cells 
had decreased expression of antioxidant genes SCARA3 isoform 2 (0.59‑fold, P = 0.02) and FOXM1 isoform 
1 (0.61‑fold, P = 0.03). KC cells also had downregulation of the antioxidant genes SOD1 (0.4‑fold, P = 0.0001) 
and SOD3 (0.37‑fold, P = 0.02) but increased expression of SOD2 (3.3‑fold, P < 0.0001), PRDX6 (1.47‑fold, 
P = 0.01), and CPSF3 (1.44‑fold, P = 0.02). 
Conclusion: The difference in expression of antioxidant enzymes between KC and NL suggests that the 
oxidative stress imbalances found in KC are caused by defects in ROS/RNS removal rather than increased 
ROS/RNS production.
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INTRODUCTION
Keratoconus (KC) is a progressive corneal thinning 
disorder that causes irregular astigmatism and reduced 
vision. It affects approximately 1 in 375 individuals and 
is an indication for corneal transplant surgery.[1‑4] In about 
6%–10% of cases, KC reportedly has an autosomal dominant 
inheritance pattern with incomplete penetrance.[5‑7] The 
mechanism(s) causing KC are not known but are thought 
to involve a combination of genetic and environmental 
factors. The cornea is constantly exposed to ultraviolet 
light, which is a common source of free radicals and 
reactive oxygen/nitrogen species (ROS/RNS). Numerous 
molecular and biochemical studies have reported elevated 
levels of oxidative damage in corneas, cultured cells, and 
tears from eyes with KC.[8‑11] Oxidative stress causes tissue 
degradation,[12] which may contribute to stromal thinning 
and loss of Bowman’s layer in a cornea with KC.[1,2] Ex 
vivo corneas with KC contain biochemical markers for 
peroxynitrites and malondialdehydes, which are cytotoxic 
byproducts of the nitric oxide and lipid peroxidation 
pathways, respectively.[8] Peroxynitrites (ONOO‑), formed 
by the combination of superoxides (O•-) with nitric 
oxides [Figure 1], can damage DNA, proteins, and lipids. 
An increase in oxidative stress is associated with inherited 
and acquired mitochondrial dysfunction.[13] Pathak et al 
identified mutations in complex 1 genes that are pathogenic 
and exclusive to KC.[14] Corneas with KC also have elevated 
levels of mitochondrial DNA (mtDNA) damage along with 
decreased levels of mitochondrial‑encoded cytochrome c 
oxidase (complex IV subunit 1, MTCO1), consistent with 
mitochondrial dysfunction.[15]
Evidence of the oxidative stress seen in corneas 
with KC has also been found in cultured KC cells. 
KC fibroblasts have higher levels of ROS/RNS and 
caspase‑3/7 activity in vitro, along with altered levels of 
cytochrome c oxidase (complex IV subunit II, MTCO2), a 
decreased mitochondrial membrane potential, degraded 
mtDNA, and increased activation of the caspase‑9 
mitochondrial pathway.[9,16] There is normally a balance 
between the amounts of ROS and RNS produced and 
eliminated with antioxidants, but this balance is altered 
in patients with KC, even on a systemic level.[17,18]
The present study was designed to evaluate the key 
components involved in the balance of oxidative stress 
elements. On the production side, we measured gene 
expression levels for multiple subunits of NADPH oxidase, 
an enzyme responsible for production of superoxides, 
and for inducible nitric oxide synthase (NOS2), which 
produces nitric oxide [Figure 1]. On the elimination 
side, we measured the gene expression levels for nine 
antioxidant enzymes, along with SCARA3, which is a 
major ROS/RNS scavenger, and FOXM1, a transcription 
factor for antioxidant genes. Our findings suggest that 
oxidative stress likely results from a disruption of the 
elimination pathways rather than overproduction of ROS 
or RNS in corneas with KC. This finding may provide 
important guidance for future therapeutic reduction of 
oxidative damage in corneas with KC.
METHODS
Corneal Fibroblast Cultures
Six normal corneas from donors aged 24–59 (mean 40.2) 
years were received within 24 hours post mortem from the 
National Disease Research Interchange (Philadelphia, PA). 
Five corneas with KC from patients aged 25–46 (mean 34.8) 
years were received in McCarey‑Kaufman medium on ice 
within 24 hours of penetrating keratoplasty. The donors 
and patients were matched for age and sex. The study was 
performed according to the tenets of the Declaration of 
Helsinki for research involving human subjects and a written 
informed consent was obtained from all study participants.
The diagnosis of KC was based on more than one of the 
following criteria: Munson’s sign, Rizzuti phenomenon, 
slit-lamp findings (e.g., stromal thinning, Vogt’s striae, 
Fleischer ring, and epithelial or subepithelial scarring); 
retroillumination signs (e.g., oil droplet sign, scissoring on 
retinoscopy); photokeratoscopy signs (e.g., infero‑temporal, 
inferior, or central compression of mires); videokeratography 
signs (e.g., localized increased surface power and/
or inferior‑superior dioptric asymmetry), and corneal 
topography. NL and KC stromal cells were isolated and 
cultured as described elsewhere.[19] When corneal stromal 
cells are cultured in 10% fetal bovine serum, they differentiate 
into fibroblasts.[20,21] Our corneal cells stained with vimentin 
(a marker for fibroblasts) but did not stain with alpha smooth 
muscle actin (a marker for myofibroblasts). The morphology 
was consistent with fibroblasts and not corneal keratocytes.
Inhibitor Studies
Third passage fibroblasts were used for the individual 
experiments (n = 4). Cells were plated overnight in phenol 
Figure 1. Schematic diagram of pathways involved in production 
and elimination of ROS/RNS. SOD, superoxide dismutase; 
NOS2, inducible nitric oxide synthase; H2O2, hydrogen 
peroxide; O•–, superoxide; ONOO– peroxynitrite; •OH, 
hydroxyl; NO2
•, Nitrogen dioxide. GPX3, glutathione 
peroxidase 3; PRDX4, peroxiredoxin 4; PRDX6, peroxiredoxin 6.
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red‑free minimum essential medium with 10% fetal bovine 
serum (Omega Scientific Inc., Tarzana, CA). Some cells 
were cultured for 2 hours with either apocynin (30 µM, 
an inhibitor of NADPH oxidase [Sigma‑Aldrich, St Louis, 
MO]) or N‑nitro‑L‑arginine (N‑LLA; 100 µM, an irreversible 
inhibitor of constitutive nitric oxide synthase [NOS]) 
and a reversible inhibitor of inducible NOS (iNOS; 
Sigma‑Aldrich). ROS/RNS levels were measured using 
a fluorescent dye (2'‑,7'‑dichlorodihydrofluorescein 
diacetate) assay (Invitrogen, Waltham, MA) as described 
previously.[9] The statistical analyses were performed 
using the unpaired t‑test.
Gene Expression Array Studies
The NL (n = 2) and KC (n = 2) corneal cell cultures were 
analyzed using the RT2 Profiler™ PCR Array for Oxidative 
Stress and Antioxidant Defense (SABiosciences, 
Frederick, MD). RNA was isolated using the RNeasy 
Mini Kit (Qiagen, Inc., Valencia, CA) following the 
manufacturer’s protocol. For the complementary DNA 
synthesis, 1 µg of RNA was used for the RT2 First Strand 
Kit (SABiosciences) according to the manufacturer’s 
protocol. The complementary DNA was then processed 
at the UCLA Sequencing Core Facility (Los Angeles, CA). 
The analyses were performed using the SA Biosciences 
RT2 array analysis software.
Quantitative PCR Analyses
After our initial screen using the Oxidative Stress 
and Antioxidant Defense array, we performed 
quantitative polymerase chain reaction (Q‑PCR) on 
enzymes associated with production and elimination 
of ROS/RNS in the NL (n = 6) and KC (n = 5) 
cultures. The NADPH oxidase family consists 
of 7 isoforms, each consisting of a core catalytic 
subunit (NOX and DUOX) with up to 5 regulatory 
subunits [Figure 2]: p22phox (CYBA), p67phox (NCF2), 
and p47phox (NCF1).[22] Gene expression analyses 
were also performed for antioxidant enzymes 
responsible for ROS/RNS elimination, i.e., CAT, 
GPX3, PRDX3, PRDX4, PRDX6, SOD1, SOD2, SOD3, 
and USP36. Isoforms for SCARA3, a ROS scavenger, 
were evaluated along with CPSF3, a processing 
endonuclease associated with SCARA3. The expression 
levels for FOXM1 (a transcription factor for antioxidant 
enzymes) were measured. The primers for the total 
FOXM1 and isoform 1 FOXM1 were available but not 
for isoforms 2 or 3. Q‑PCR primers were purchased 
from Qiagen.
RNA was extracted from the pellets of the 
cultured cells using the RNeasy Mini Kit (Qiagen) 
according to the manufacturer’s instructions and 
quantified on a Nanodrop 2000. Next, 500 ng of 
RNA was reverse‑transcribed into complementary 
DNA using the QuantiTect Reverse Transcription 
Kit (Qiagen). The Q‑PCR was carried out with the 
QuantiFast SYBR Green PCR Kit (Qiagen) according 
to the manufacturer’s protocol, using β2‑microglobulin 
primers (forward, CTCGCGCTACTCTCTCTTTCTG; 
reverse, GCTTACATGTCTCGATCCCACTT) and TATA 
box binding protein (Qiagen) as the housekeeping 
genes. The data were analyzed using GraphPad Prism 
5 (GraphPad Software Inc., La Jolla, CA).
Immunohistochemistry Studies
Ten NL corneas and 10 KC corneas were examined 
by immunohistochemistry using the rabbit polyclonal 
antibody to Scavenger Receptor Class A, Member 3 
protein (SCARA3, GeneTex, Irvine, CA) or the rabbit 
polyclonal antibody to Cleave and Polyadenyl Specific 
Factor 3 (CPSF3, GeneTex). The secondary antibody 
was the Alexa FluorÒ 555 goat anti‑rabbit IgG (H + L; 
Invitrogen). The corneas were embedded in Tissue‑Tek 
OCT compound (Sakura Finetek USA Inc., Torrance, CA) 
prior to freezing in liquid nitrogen. Tissue sections were 
cut, mounted onto microscope slides, and stored at −80°C. 
The tissues were counterstained with DAPI (Invitrogen). 
Slide images were captured with a Nikon E600 fluorescent 
microscope and MetaMorph software. The epithelial 
and stromal staining patterns were examined using a 
subjective 0–4+ scoring system (0, little or no staining; 1+, 
weak staining; 2+, moderate staining; 3+, intense staining; 
and 4+, very intense staining).
Statistical Analysis
The statistical analysis was performed using Simple 
Interactive Statistical Analysis (SISA) Internet software 
(Quantitative Skills, Amsterdam, the Netherlands) and the 
Student’s t‑test using GraphPad Prism software.
Figure 2. Schematic diagram of subunits associated with the 
NADPH oxidase enzyme. The p22phox subunit is utilized by 
NOX1‑NOX4 but not the NOX5, DUOX1, or DUOX2 enzymes. 
The p47phox subunit is utilized by NOX1 and NOX2. The 
p67phox and p40phox subunits are only associated with NOX2.
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RESULTS
Pathways for Production of ROS/RNS
Studies were performed to determine if  the 
ROS/RNS levels in NL and KC cultures could be 
altered by pre‑treatment with apocynin, an inhibitor of 
NADPH oxidase, or N‑LLA, an inhibitor of NOS. The 
KC cultures (n = 5) had a 1.8‑fold increase in ROS/RNS 
levels compared to untreated NL cultures (P = 0.004), 
which could not be reversed by pre‑treatment with 
apocynin (P = 0.9) or N‑LLA (P = 0.8; Figure 3). These 
inhibitor studies indicated that the higher ROS/RNS 
levels found in KC cultures could not be reversed by 
blocking the NADPH oxidase or NOS pathways. The 
mechanism of action of apocynin involves inhibition 
of the association of the NADPH oxidase p47phox 
subunit with the membrane‑bound heterodimer[22] and 
we reasoned that perhaps the p47phox subunit was 
diminished in human corneal fibroblasts. The gene 
expression patterns of various NADPH oxidase subunits 
were examined to ensure that our findings were not 
caused by reduced expression of the p47phox subunit 
in cultured KC cells. The p47phox subunit is associated 
with NOX1 and NOX2 but not with NOX3, NOX4, 
NOX5, DUOX1, or DUOX2. In addition to the p47phox 
subunit, the gene expression patterns of p22phox, which 
is associated with NOX1‑NOX4, DUOX1 and DUOX2, 
were also analyzed. The mRNA expression of p67phox 
was measured because it is associated with NOX2 and 
expressed in human corneal cells.[23] Table 1 shows that 
the expression patterns for p47phox, p67phox, p22phox, 
DUOX1, DUOX2, and NOS2 were not changed in KC 
cells when compared with NL cells.
Pathways for Elimination of ROS/RNS
Antioxidant genes associated with elimination of 
ROS/RNS were altered in KC cultures when compared 
with NL cultures [Table 2]. The KC cells had a significant 
reduction in gene expression for two antioxidant 
enzymes, i.e., SOD1 (NM_000454, P = 0.0001) and 
SOD3 (NM_003102, P = 0.02), while SOD2 (NM_00636, 
NM_001024465, P = 0.0001) and PRDX6 (NM_004905, 
P = 0.01) had increased expression. The levels for USP36, 
CAT, GPX3, and PRDX4 were similar in NL cells and 
KC cells.
SCARA3 (also known as CSR1 and MSR1) is a ROS 
scavenger that protects cells against ultraviolet light. The 
gene expression levels for total SCARA3 (NM_016240, 
NM_182826) and the full‑length isoform, variant 
1 (NM_016240), were not significantly changed in 
comparison with NL cells [Table 3]. The shorter 
SCARA3 variant 2 (NM_182826, see lower panel) 
showed a 0.59‑fold decrease (P = 0.02) in the KC cells 
when compared with the NL cells. The gene expression 
levels for CPSF3, a pre‑mRNA 3‑prime end‑processing 
endonuclease that is closely associated with SCARA3,[24] 
was significantly increased in the KC cells (1.44-fold, 
P = 0.0017).
Given that SCARA3 and CPSF3 have not been previously 
identified in human corneas, immunohistochemistry was 
performed on NL and KC corneas with SCARA3-specific 
and CPSF3-specific antibodies [Figure 4]. The SCARA3 and 
CPSF3 proteins were present in stromal cells in both NL and 
KC corneas (box inserts). Surprisingly, we found the greatest 
staining for the SCARA3 protein in the NL epithelium (+4 
in 4 samples and + 3 in 6 samples) with slightly less in the 
KC epithelial cells (+3 in 7 samples and +2 in 3 samples).
Figure 3. KC cells have significantly elevated ROS/RNS levels 
compared with NL cells (1.8‑fold, ***P = 0.004). Pretreatment 
for 2 hours with 30 μM apocynin (an inhibitor of NADPH 
oxidase) or 100 μM N‑nitro‑L‑arginine (an inhibitor of nitric 
oxide synthase) did not decrease the ROS/RNS levels to 
those in NL cells. KC, keratoconus; NL, normal; RNS, reactive 
nitrogen species; ROS, reactive oxygen species.
Figure 4. Immunohistochemistry shows SCARA3 staining in NL 
and KC corneas. The epithelial cells have a distribution of SCARA3 
throughout the cytoplasm of the NL and KC corneas. The CPSF3 
protein staining is found within the cytoplasm of the epithelial 
cells and stromal cells. No staining was observed when only the 
secondary antibody (IgG) was used on the tissue sections (negative 
control). NL, normal; KC, keratoconus, E, epithelial; S, stroma.
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Expression for the FOXM1 isoform 1, an important 
transcription factor for antioxidant genes, was 
significantly decreased in KC cells [Table 4]. In these cells, 
expression of the FOXM1 isoform variant 1 (NM_202002) 
was decreased by 0.61‑fold (P = 0.03). This full‑length 
FOXM1 isoform has 10 exons and contains 3641 bp. Exon 
9 is missing in isoform variant 2 of FOXM1 (NM_021953), 
while both exons 6 and 9 are missing in isoform variant 
3 of FOXM1 (NM_202003).
DISCUSSION
Pathways for Production of ROS/RNS
The major source of superoxides in human corneal 
stromal fibroblasts has been reported to be through 
the NADPH oxidase pathway.[23] Our results support 
this finding and show that NL and KC human corneal 
fibroblasts have similar expression levels of p22phox, 
p47phox, and p67phox NADPH oxidase subunits. 
Table 1. Differential Gene Expression in Normal Cells (n=6) Compared to KC Cells (n=5)
Symbol Gene Name GeneBank 
Accession No.
Function P ΔΔCT Fold
DUOX2, 
LNOX1
Dual oxidase 2 NM_014080 Direct release of 
hydrogen peroxide
0.06 ‑0.81±0.41 0.57
DUOX1, 
LNOX2
Dual oxidase 2 NM_175940
NM_017434
Direct release of 
hydrogen peroxide
0.59 ‑0.41±0.75 0.75
NCF1, 
p47phox
Neutrolphil cytosolic 
factor 1
NM_000265 Organization subunit for 
NADPH oxidase
0.13 0.94±0.6 1.9
NCF2, 
p67phox
Neutrolphil cytosolic 
factor 2
NM_000433
NM_001127651
NM_001190789
NM_001190794
Activation subunit for 
NADPH oxidase
0.74 0.21±0.64 1.2
CYBA, 
p22phox
Cytochrome b‑245, 
alpha polypeptide 
NM_000101 Maturation subunit for 
NADPH oxidase
0.09 ‑0.58±0.34 0.67
NOS2 Nitric oxide synthase 2 NM_153292
NM_000625
Inducible NOS, 
production of nitric oxide
0.11 ‑0.46±0.28 0.73
Fold values greater than 1 indicate up regulation of the gene compared to NL cells. Fold values less than 1 indicate down regulation of the 
gene compared to NL cells. NL cells are assigned a value of 1. Fold=2-ΔΔCT
Table 2. Differential Expression of Antioxidant Enzyme Genes in Normal Cells (n=6) and KC Cells (n=5)
Symbol Gene Name GeneBank 
accession no.
Function P ΔΔCT Fold
CAT Catalase NM_001752 Heme enzyme that converts reactive 
oxygen species to H2O and O2
0.139 ‑0.47±0.31 0.72
GPX3 Glutathione 
peroxidase 3 (plasma)
NM_002084 Detoxifies H2O2 0.069 1.03±0.55 2.05
PRDX3 Peroxiredoxin 3 NM_006793 Antioxidant enzyme localized in the 
mitochondria
0.17 0.23±0.16 1.2
PRDX4 Peroxiredoxin 4, 
AOE37‑2
NM_006406 Redox regulation, reduces H2O2 & 
hydroyperoxides
0.08 ‑0.63±0.35 0.65
PRDX6 Peroxiredoxin 6, 
1‑Cys, AOP2
NM_004905 Redox regulation, reduces H2O2 & 
hydroyperoxides
0.01 0.56±0.21 1.47
SOD1 Superoxide 
dismutase 1, soluble
NM_000454 Copper and zinc binding antioxidant 
enzyme that destroys free superoxide 
radicals
0.0001 ‑1.28±0.28 0.4
SOD2 Superoxide 
dismutase 2, 
mitochondrial
NM_000636
NM_001024465
Manganese binding antioxidant enzyme 
that converts superoxide byproducts of 
oxidative phosphorylation to H2O2 and O2
<0.0001 1.74±0.3 3.3
SOD3 Superoxide 
dismutase 3, 
extracellular
NM_003102 Antioxidant enzyme that catalyzes the 
dismutation of 2 superoxide radicals in to 
H2O2 and O2
0.02 ‑1.43±0.57 0.37
USP36 Ubiquitin Specific 
Peptidase 36
NM_025090 Deubiquinating cysteine protease 0.19 0.31±0.23 1.24
Fold values greater than 1 indicate up regulation of the gene compared to NL cells. Fold values less than 1 indicate down regulation of the 
gene compared to NL cells. NL cells are assigned a value of 1. Fold=2-ΔΔCT
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Analyses of other genes in the NADPH oxidase family 
showed expression of DUOX1 and DUOX2 in human 
NL and KC corneal cells. Unlike other NADPH oxidase 
family members that produce superoxides that are then 
converted into hydrogen peroxides, the DUOX1 and 
DUOX2 oxidases are NADPH oxidase homologues 
that directly produce hydrogen peroxide.[25,26] Although 
DUOX1 and DUOX2 proteins have been previously 
reported in thyroid cells, epithelial cells in the airway, 
prostate cells, salivary glands, and gastrointestinal 
cells,[27] their roles in human corneal cells are unclear 
at this time and warrant further investigation. No 
differences in any of the NADPH oxidase enzymes were 
found between NL and KC cells, so we concluded that 
it was unlikely that the elevated ROS/RNS levels in KC 
cells were the result of increased NADPH oxidase‑related 
production.
While Buddi et al observed that KC stromal cells 
show increased accumulation of iNOS protein,[8] our 
KC and NL cell cultures showed similar expression 
levels of iNOS. Peroxynitrite and nitric oxide are toxic 
to corneal cells due to inducing gelatinase/matrix 
metalloproteinase (MMP)‑2 activity and diminishing 
TIMP-1 levels, reflecting a direct relationship between 
elevated oxidative stress and tissue degradation.[12,28] 
Activation of MMPs, such as MMP‑2 and proxidase, is 
important in the degradation and remodeling of collagen 
in the corneal stroma.[29] Oxidative stress‑induced 
activation of MMPs and abnormal enzyme levels 
contribute to the stromal thinning and loss of Bowman’s 
layer which are characteristics of KC.
Pathways for Elimination of ROS/RNS
An alternative mechanism for accumulation of ROS/RNS 
is decreased removal of the oxidants once they are formed. 
Screening of 84 antioxidant‑related genes showed 12 genes 
that were differentially expressed between the NL and 
KC cultures. These were further analyzed with Q‑PCR 
and showed depressed expression levels of SOD1 and 
SOD3, both of which are critical antioxidant enzymes 
that convert superoxide to hydrogen peroxide. The SOD1 
gene (cytosolic copper‑zinc SOD) is on chromosome 21 
and has been linked to KC through a deletion within intron 
2 that segregates in affected family members.[30,31] This 
deletion was recently reported in subjects with sporadic 
KC,[32] contrasting with other studies that did not find this 
defect in association with KC.[33] The enzyme activity for 
SOD3 (extracellular matrix SOD) was also lower in corneas 
with KC.[34] SOD1‑null and SOD3‑null mouse models 
showed elevated superoxide levels in the corneas, which 
could contribute to oxidative damage.[35] Furthermore, it 
is reasonable to propose that lower antioxidant enzyme 
levels in KC cells may lead to increased accumulation of 
ROS/RNS, as seen in our cultured KC cells.
SOD2 is a tetrameric enzyme that contains manganese 
and is located in the matrix of the mitochondria. Previously, 
it has been shown in an American population[15] and in 
a Chinese population[36] that corneas with KC have 
Table 3. Differential Gene Expression of SCARA3, a ROS Scavenger, in Normal Cells (n=6) and KC Cells (n=5)
Symbol Gene Name GeneBank 
Accession No.
Function P ΔΔCT Fold
SCARA3, 
Total
Scavenger receptor class A, 
member 3
NM_016240
NM_182826
Depletes ROS, protects cells 
from oxidative stress generated 
from UV light
0.57 0.18±0.31 1.13
SCARA3, 
Isoform 1
Scavenger receptor class A, 
member 3
NM_016240 Depletes ROS, protects cells 
from oxidative stress generated 
from UV light
0.29 ‑0.29±0.27 0.82
SCARA3, 
Isoform 2
Scavenger receptor class A, 
member 3
NM_182826 Depletes ROS, protects cells 
from oxidative stress generated 
from UV light
0.02 ‑0.75±0.3 0.59
CPSF3 Cleavage and polyadenylation 
specificity factory 3
NM_016207 Pre‑mRNA 3‑prime‑ 
end‑processing endonuclease
0.0017 0.53±0.15 1.44
Fold values greater than 1 indicate up regulation of the gene compared to NL cells. Fold values less than 1 indicate down regulation of the 
gene compared to NL cells. NL cells are assigned a value of 1. Fold=2-ΔΔCT
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more mtDNA damage than normal corneas. While 
the Chinese study found that expression of SOD2 was 
lower in corneas with KC than in normal corneas,[36] it 
was 3.3‑fold higher in KC cells than in NL cells in the 
present study. Interestingly, Ortak et al reported that 
subjects with KC had higher total plasma SOD levels than 
subjects without KC.[37] These conflicting findings point to 
a need for additional studies to explain this discrepancy 
and whether increased mtDNA damage has stimulating 
or inhibiting effects on transcription of SOD2. Based 
on the results of this study and other previous studies, 
the elimination patterns for ROS/RNS are significantly 
altered in subjects with KC and in KC cell cultures, which 
can contribute to oxidative damage and enzymatic matrix 
degradation, which are key features in corneas with KC.
PRDX6 is a redox regulation enzyme that reduces 
levels of hydrogen peroxide and phospholipid 
hydroperoxides and protects cells against oxidative 
injury and inflammation.[38] We found that expression 
levels of PRDX6 were higher in KC cells than in NL cells. 
Differential expression of peroxiredoxin isoforms has 
been associated with Fuchs’ endothelial dystrophy.[39] In 
human ovarian cancer cells, its overexpression reduces 
ROS levels and caspase activity and stops cells from 
undergoing apoptosis.[40] Given the altered levels of 
numerous antioxidant enzymes, corneas with KC would 
have altered levels of superoxides and hydrogen peroxide, 
which could dramatically change cell signaling cascades, 
cytokine levels, and degradative enzyme activity.
The KC cells showed a significant decrease in isoform 
2 SCARA3 gene expression when compared to the NL 
cells. SCARA3, located at chromosome 8p21, is a critical 
scavenger protein that depletes ROS and thereby protects 
cells from oxidative stress. When in the unstressed 
state, SCARA3 is localized to the Golgi apparatus in 
the endoplasmic reticulum; however, upon exposure to 
hydrogen peroxide, SCARA3 scavenger proteins diffuse 
into the cytoplasm[41] where they transport free radicals 
to lysosomes for processing and removal. SCARA3 has 
two alternatively spliced variants. The shorter SCARA3 
isoform (CSR2, NM_182826), which is present at lower 
levels in KC cells, lacks the collagen‑like domain, has 
exon 6 shortened to 258 bp with a shorter C‑terminal tail, 
and codes for a 466‑amino acid protein. SCARA3/CSR1 
isoform 1 (NM_01240) contains 3631 bp with a full‑size 
exon 6 and a long poly(A)3' tail. The predicted 606‑amino 
acid protein has a leucine zipper motif that overlaps 
at its N‑terminus with a transmembrane domain and 
two collagen‑like domains. The protein has numerous 
phosphorylation and N‑glycosylation sites, a putative 
heme‑binding site, and microbody‑targeting signals.
Normal skin fibroblasts exposed to ultraviolet light 
or hydrogen peroxide show significantly elevated 
CSR/SCARA3 expression, which can be reversed by 
pretreatment with antioxidant compounds.[41] Cells 
overexpressing CSR1/SCARA3 or CSR2/SCARA3 have 
increased resistance to damage caused by ultraviolet 
light.[41] This feature is an important property for corneal 
cells that are constantly being exposed to sunlight. The 
collagenous domains of the full‑length CSR1/SCARA3 
isoform can bind lipids and other negatively charged 
molecules, such as fibrinogen and laminins. The shorter 
splice variant CSR2/SCARA3 lacks these collagenous 
domains, which could contribute to functional behavior 
different from that of the full‑length CSR1/SCARA3. 
The significance of decreased SCARA3 in KC cells is 
Table 4. Differential Gene Expression of FOXM1 Transcription Factor in Normal Cells (n=6) and KC Cells (n=5)
Symbol Gene Name GeneBank
Accession No.
Function P ΔΔCT Fold
FOXM1, Total Forkhead box M1 NM_021953
NM_202002
NM_202003
Transcription factor of antioxidant genes 0.6 ‑0.25±0.49 0.84
FOXM1 Isoform 1 Forkhead box M1 NM_202002 Transcription factor of antioxidant genes 0.03 ‑0.72±0.32 0.61
Fold values greater than 1 indicate up regulation of the gene compared to NL cells. Fold values less than 1 indicate down regulation of the 
gene compared to NL cells. NL cells are assigned a value of 1. Fold=2-ΔΔCT
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not known, but one could speculate that lower levels of 
this important scavenger would result in elevated levels 
of ROS/RNS and the increased apoptosis of anterior 
stromal cells found in corneas with KC.[42] Another 
mechanism by which CSR/SCARA3 may affect KC cells 
is via its association with CPSF3, an enzyme necessary 
for polyadenylation of RNA.[43,44] The CPSF3 protein is a 
critical pre‑mRNA 3‑prime end‑processing endonuclease 
that converts heteronuclear RNA to mRNA.[24] Increased 
levels of CPSF3, as seen in KC cells, potentially alter 
patterns of cell death and other cell functions. Zhu et al 
showed that the C‑terminus of CSR1/SCARA3 interacts 
with CPSF3, which is then translocated from its location in 
the nucleus to a cytosolic distribution.[45] In KC cells, there 
were significantly higher expression levels of SCARA3 
isoform 2, which has a shortened C‑terminus. This altered 
expression could potentially affect pre‑mRNA processing 
within the cells and might account for the numerous 
altered genes reportedly found in corneas with KC.[46‑48]
Altered Gene Regulation
Our data, along with those of others, suggest that KC cells 
have abnormalities in multiple antioxidant pathways that 
contributes to the pathology of KC. The present study 
showed that KC cells had a 0.61‑fold decline in FOXM1 
isoform 1 (NM_202002). FOXM1 is in the Forkhead Box 
transcription factor family that has a conserved winged 
helix DNA domain and is a transcription factor for 
antioxidant enzymes. It has dual functions involving cell 
cycle progression and also tumor cell migration/invasion. 
FOXM1 promotes cell growth by regulating genes 
involved in DNA repair, mitosis, chromatin assembly, 
and protein metabolism.[49,50] In tumors, high FOXM1B 
expression levels are correlated with a poor prognosis.[49] 
FOXM1 plays an essential role in regulation of oxidative 
stress[51] and modulates intracellular ROS levels by 
upregulating expression levels of antioxidant genes 
that protect cells from oxidative damage. Fibroblasts 
with FOXM1 silenced by siRNA transfection become 
significantly less viable after treatment with hydrogen 
peroxide.[51] Low levels of FOXM1 in KC cells result in 
diminished expression of antioxidant genes and potential 
accumulation of ROS/RNS within these cells. This would 
render KC cells more susceptible to oxidative damage 
and less able to survive exposure to stressors, such as 
hydrogen peroxide or low pH.[9,16]
In summary, our findings suggest that the elevated 
ROS/RNS levels found in KC cells are more likely to 
reflect less efficient elimination of these oxidants rather 
than overproduction. The antioxidant quercetin is a 
potential therapy that may address both the elimination 
of oxidants as well as regulation of metabolism in corneas 
with KC, considering that excessive lactate production 
has been associated with oxidative stress and KC.[52‑54] 
Future studies should focus on therapeutic agents that 
can bring the ROS/RNS balance into equilibrium and 
reduce oxidative damage in corneas with KC.
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